Form D Explorer
Thiogenesis Therapeutics, Corp. · CIK 1877778

Report a data issueCitable research briefCompare issuerPrivate research collection

Thiogenesis Therapeutics, Corp.

CIK 1877778 · Corporation · Inc. ONTARIO, CANADA · TORONTO, Ontario, Canada · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Aug 8, 2025
through Jun 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldAug 8, 2025 · DJun 9, 2026 · DLater minus earlier
Reported offering amount$125,450$28,964$-96,486
Reported amount sold$125,450$28,964$-96,486
Reported investor count—0—
Reported minimum investment$0$0$0

Earlier SEC source: 0001062993-25-013902 · Later SEC source: 0001062993-26-003123

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Jun 9, 2026

Reported offering amount
$28,964
Reported exemptions
Rule 506(b)
Reported amount sold
$28,964

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)